¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"serum response element"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • serum-fast
    Ç÷ûÀúÇ×¼º-
  • arousal response
    °¢¼º¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • alerting response
    °¢¼º¹ÝÀÀ
  • anamnestic response
    ¸é¿ª±â¾ï¹ÝÀÀ
  • biologic response modifier
    »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
  • biological response modifier
    »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
  • brain stem evoked response audiometry
    ³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • conditioned response
    Á¶°Ç¹ÝÀÀ
  • consummatory response
    ¼ºÃë¹ÝÀÀ
  • cell-mediated response
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • chemotactic response
    È­ÇÐÁÖ¼º¹ÝÀÀ, È­Çнò¸²¹ÝÀÀ
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • specific serum
    ƯÀÌÇ÷û
  • standard serum
    ±âÁØÇ÷û
  • alerting response
    °¢¼º¹ÝÀÀ
  • anamnestic response
    (¢¡secondary immune response) ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • arousal response
    °¢¼º¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • brainstem evoked response audiometry
    ³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
  • evoked response audiometry
    À¯¹ß¹ÝÀÀû·Â°Ë»ç
  • galvanic skin response audiometry
    ÇǺÎÀü±â¹ÝÀÀû·Â°Ë»ç
  • startle response audiometry
    ³î¶÷¹ÝÀÀû·Â°Ë»ç
  • stimulus response assessment
    ÀڱعÝÀÀÆò°¡
  • biologic response modifier
    »ýü¹ÝÀÀÁ¶Àý¹°Áú, »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦
  • bulbocavernous evoked-response test
    ¸Á¿ïÇØ¸éü±ÙÀ¯µµ¹ÝÀÀ°Ë»ç
  • response bias
    ¹ÝÀÀ¹ÙÀ̾
  • cell-mediated response
    ¼¼Æ÷¸Å°³¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cherons serum
    »þ·Î¿ìÇ÷û.
  • Glutamine-oxaloacetic transaminase, serum
    ±Û·çŽ¿Á»ì¾Æ¼¼Æ®»ê Ʋ¶õ½º¾Æ¹Ì³ªÁ¦
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • Loefflers coagulated serum medium
    ·ÚÇ÷¯ÀÀ°íÇ÷û»ç¸é¹èÁö
  • Loefflers serum slant
    ·ÚÇ÷¯ Ç÷û»ç¸é¹èÁö
  • Luton s serum
    ·çÅæÇ÷û.
  • RISA=£¾radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÇ÷û¾ËºÎ¹Î.
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • U/S osmol ratio => urine/serum osmol ratio
    ¼Òº¯/Ç÷û ¿À½º¸ôºñ
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè(ß«àõûùúìôèãËúÐ).
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè
  • acidified serum test=Ham test
    »ê¼ºÈ­Ç÷û°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • unit element
    ´ÜÀ§¿ø(Ó¤êÈêª).
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè(ß«àõûùúìôèãËúÐ).
  • acidified serum test=Ham test
    »ê¼ºÈ­Ç÷û°Ë»ç
  • acidified-serum lysis test=Ham test
    »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
  • allergenic serum
    ¾Ë·¹¸£°Õ¼º Ç÷û(ÊÙ̴̧).
  • antilymphocyte(-tic) serum
    Ç׸²ÇÁ±¸Ç÷û (¡­úìôè).
  • antiplatelet serum
    Ç×Ç÷¼ÒÆÇÇ÷û(¡­úìôè).
  • antirabies serum
    Ç×±¤°ßº´Ç÷û(ù÷ÎÊ̳ܻ úìôè).
  • antitetanic serum
    ÇׯĻódzÇ÷û(¡­úìôè).
  • antithymocyte serum
    Èä¼±¼¼Æ÷Ç×Ç÷û, °¡½¿»ù¼¼Æ÷Ç×Ç÷û
  • antitoxic serum
    Ç×µ¶¼Ò(¼º) Ç÷û(¡­úìôè).
  • antitoxic serum
    Ç×µ¶(¼Ò)¼º Ç÷û
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • PI response
    PI ´ëÀÀ(Óßëë)
  • pleiotypic response
    ´Ù¸é ´ëÀÀ(ÒýØüÓßëë)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary response
    ÀÏÂ÷ ´ëÀÀ(ìéó­Óßëë)
  • SOS response
    SOS ´ëÀÀ(Óßëë)
  • staircase response
    °è´Ü ´ëÀÀ(Í­Ó«Óßëë)
  • stringent response
    ¾ö°Ý ´ëÀÀ(åñÌ«Óßëë)
  • tertiary response
    »ïÂ÷´ëÀÀ (ß²ó­Óßëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MLR mean length response; middle latency response; mixed lymphocyte reaction
PR by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr...
RVR reduced vascular response; renal vascular resistance; repetitive ventricular response; resistance to...
SER sebum excretion rate; sensitizer enhancement ratio; sensory evoked response; service; smooth endopla...
SIRS soluble immune response suppressor; Structured Interview of Reported Symptoms; systemic inflammatory...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PPRE Peroxisome Proliferator Response Element
PRE Polycomb Response Element
RARE RA response element
RRE REV response element
RARE retinoic acid response element
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • Banzhaf serum
    ¹ÝÃ÷ÇÏÇÁ Ç÷û
    ³óÃà Ç×Æó¿°±Õ Ç÷û.
  • Bardel's serum
    ¹Ù¾Æµ¨ Ç÷û
  • blood serum
    Ç÷û
    1. Ç÷¾×ÀÌ ¿ÏÀüÈ÷ ÀÀ°íµÈ ´ÙÀ½ Ç÷¾×¿¡¼­ À¯¸®µÈ Åõ¸íÇÑ ¾×ü·Î, ÀÀ°í °úÁ¤¿¡ À־ Ç÷ÀåÀ¸·ÎºÎÅÍ ¼¶À¯¼Ò¿øÀÌ Á¦°ÅµÈ °Í. 2. Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿øÀ» Á¦°ÅÇÑ ³ª¸ÓÁö. »ýü¿¡¼­ äÃëÇÑ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö¾î Á¶¿ëÈ÷ ¼¼¿öµÎ¸é ¸ÕÀú ÀÀ°íÇÏ¿© ÀÀÇ÷ÀÌ µÇ°í, À̰ÍÀÌ ¼öÃàÇÏ¿© ¾ÏÀû»öÀÇ µ¢¾î¸®ÀÎ Ç÷º´°ú ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×üÀÎ Ç÷ûÀ¸·Î ³ª´©¾îÁø´Ù. Áï, Ç÷¾×¿¡¼­ À¯Çü ¼ººÐ ÀÌ¿ÜÀÇ ºÎºÐÀº Ç÷ÀåÀε¥, ÀÌ Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿ø
  • foreign serum
    ÀÌÁ¾ Ç÷û
  • horse serum
    ¸» Ç÷û
    ¸»ÀÇ Ç÷¾×¿¡¼­ ¾ò¾îÁö´Â Ç÷û.
  • human serum immune globulin
    Àΰ£ Ç÷û ¸é¿ª ±Û·ÎºÒ¸°
  • immune serum
    ¸é¿ª Ç÷û
    ¾î¶² Ç׿ø¿¡ ´ëÇÑ Æ¯ÀÌÀû Ç×ü¸¦ ÇÔÀ¯Çϰí ÀÖ´Â Ç÷û. Ç×Ç÷ûÀ̶ó°íµµ ÇÑ´Ù. Áúº´ Ä¡·á
  • immune serum globulin
    ¸é¿ª Ç÷û ±Û·ÎºÒ¸°
  • Luton's serum
    ·çÅæ Ç÷û
  • polyvalent serum
    ´Ù°¡ Ç÷û
  • radioiodinated serum albumin
    ¹æ»ç¼± ¿ä¿ÀµåÈ­ Ç÷û ¾ËºÎ¹Î
  • rapid serum amylase test
    ±Þ¼Ó Ç÷û ¾Æ¹Ð·¹À̽º ½ÃÇè
  • serum albumin
    Ç÷û ¾ËºÎ¹Î
    Ç÷û Áß ÃÑ ´Ü¹éÁúÀÇ ¾à 60%¸¦ Â÷ÁöÇÏ°í »ý¸®ÇÐÀû ¿ªÇÒÀº »ïÅõ¾ÐÀÇ À¯ÁöÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
conditioned response A response already in an individual's repertoire but which, through repeated pairings with its natural stimulus, has been acquired or conditioned anew to a previously neutral or conditioned stimulus.
See: conditioning.
Compare: unconditioned response.
(05 Mar 2000)
Cushing response A rise in systemic blood pressure when the intracranial pressure acutely increases, usually in excess of 50% of the systolic arterial pressure.
Synonym: Cushing effect, Cushing response.
(05 Mar 2000)
primary antibody response <immunology> Antibodies made upon first exposure to an antigen, mostly of the class IgM.
(05 Mar 1998)
primary immune response <immunology> The immune response to the first challenge by a particular antigen. Usually less extensive than the secondary immune response, being slower and shorter lived with smaller amounts of lower affinity antibody being produced.
(18 Nov 1997)
heat-shock response <cell biology> A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins.
(12 Dec 1998)
Henry-Gauer response Inhibition of antidiuretic hormone secretion due to a rise in atrial pressure which stimulates atrial stretch receptors.
(05 Mar 2000)
satiety response Behavioural response associated with the achieving of gratification.
(12 Dec 1998)
psychogalvanic response A change in electrical resistance of the skin, occurring in emotion and in certain other conditions.
(12 Dec 1998)
secondary antibody response An antibody made upon second (subsequent) exposure to an antigen, mostly of the class IgG.
(09 Oct 1997)
secondary immune response The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen.
(18 Nov 1997)
humoral immune response <immunology> Those immune responses mediated by antibody.
(06 Mar 1998)
signal response coupling The cascade of processes by which an extracellular signal (typically a hormone or neurotransmitter) interacts with a receptor at the cell surface, causing a change in the level of a second messenger for example calcium or cyclic AMP) and ultimately effects a change in the cells functioning (for example: triggering glucose uptake or initiating cell division). Can also be applied to sensory signal transduction, for example of light at photoreceptors.
(18 Nov 1997)
hypersensitive response An active response of plant cells to pathogenic attack in which the cell undergoes rapid necrosis and dies. Associated with the production of phytoalexins, lignin and sometimes callose. The response is thought to prevent a potential pathogen from spreading through the tissues.
(18 Nov 1997)
sonomotor response Widespread myogenic potential evoked by click stimulation.
(05 Mar 2000)
sos response (genetics) An error-prone mechanism or set of functions for repairing damaged microbial DNA. Sos functions (a concept reputedly derived from the sos of the international distress signal) are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á